
|Articles|August 26, 2016
Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
3
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
4
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
5














































































































































































































